Clarivate

SEPTEMBER 26, 2023

One of the critical factors determining the success of a clinical trial is the selection of appropriate clinical sites that have evidenced access to specific patient populations. Patient recruitment accounts for 32% of all trial costs and patient drop out averages 18%, according to Deloitte figures. Food and Drug Administration.

Food and Drug Administration 59

Food and Drug Administration Electronics Patients Healthcare 59

European Pharmaceutical Review

MARCH 4, 2024

Therefore, biologics identification and characterisation poses unparalleled challenges, as does their manufacturing processes and routes of administration while maintaining patient safety and clinical efficacy. Introducing virus-like particles (VLPs) is an alternative strategy for enhancing the efficacy of gene therapy applications.

Food and Drug Administration 93

Food and Drug Administration Transportation FDA Medical 93

PM360

SEPTEMBER 15, 2022

The term “patient centricity” has been around for over a decade, and since its first utterance the buzzword has been praised, dissected, criticized, and everything in between. The concept has always been worthwhile, but people within and outside of the industry have wondered whether the industry was truly becoming more patient centric?

Patients 98

Patients Healthcare Healthcare Marketing 98

PM360

OCTOBER 13, 2023

The metaverse, when integrated with recent advancements such as generative AI, can help life sciences marketers engage with healthcare professionals, patients, and caregivers in a richer, better way, leading to a more human-centric experience. For Patients: The metaverse could usher in an era of personalized health management.

Pharma 97

Pharma Education Training Healthcare 97

Pharma Marketing Network

APRIL 30, 2021

Protocols, which have remained substantively unchanged for over 30 years, often impose an immense burden on patient participants, largely due to the frequency of site visits. Across the board, from rheumatology to neurology, outcomes that matter most to patients, have traditionally not been captured in clinical trials.

Patients 52

Patients Pharma Recruitment Distribution 52